Skip to content

The effect of nebulized dexmedetomidine on blood pressures and heart rate during start of anaesthesia

The effect of preoperative dexmedetomidine nebulization on hemodynamic response to laryngoscopy and intubation:placebo controlled randomized trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/017060
Enrollment
120
Registered
2019-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexmedetomidine nebulization: 1 microgram/kg dexmedetomidine in 3-4 ml normal saline will be administered as nebulization to patients 30 minutes before induction of anaesthesia Control

Sponsors

Dr Satyajeet Misra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients posted for elective surgery will be recruited into the trial after obtaining their written informed consent. The dexmedetomidine group will receive nebulization with 1 microgram/kg dexmedetomidine diluted in 3-4 ml normal saline 30 minutes before induction of anaesthesia. Heart rate and blood pressure responses to laryngoscopy and intubation will be recorded for 10 minutes after laryngoscopy. The normal saline group (control) will receive nebulization with normal saline (3-4 ml) 30 minutes before induction of anaesthesia and heart rate and blood pressure responses to laryngoscopy and intubation will be recorded for 10 minutes after laryngoscopy.

Exclusion criteria

Exclusion criteria: Patients who undergo emergency surgeries, have known or unanticipated difficult airway and those who are on anti-hypertensive medications will be excluded from the trial.

Design outcomes

Primary

MeasureTime frame
Changes in heart rate and blood pressure between the two groupsTimepoint: Upto 10 minutes following laryngoscopy

Secondary

MeasureTime frame
Postoperative nausea and vomiting and sore throatTimepoint: First 2 hours following surgery

Countries

India

Contacts

Public ContactDR SATYAJEET MISRA

AIIMS Bhubaneswar

misrasatyajeet@gmail.com9438884048

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026